Tag: clinical trials

Using Pharmacy Manual, Lab Manual, Imaging Manual to Strengthen Submission Packages and Health Authority Reviews

Posted on By digi

Using Pharmacy Manual, Lab Manual, Imaging Manual to Strengthen Submission Packages and Health Authority Reviews Using Pharmacy Manual, Lab Manual, Imaging Manual to Strengthen Submission Packages and Health Authority Reviews The process of preparing submission packages for clinical trials, especially when seeking regulatory approval from health authorities such as the FDA, EMA, or MHRA, is…

Read More “Using Pharmacy Manual, Lab Manual, Imaging Manual to Strengthen Submission Packages and Health Authority Reviews” »

Pharmacy Manual, Lab Manual, Imaging Manual

Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions

Posted on By digi

Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions Introduction to Reporting in Clinical Trials Clinical trials are essential for advancing medical research and providing new therapies for various diseases. However, with complex regulations and oversight mechanisms in place, understanding the reporting requirements for…

Read More “Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions” »

Regulatory Notifications & IRB Reporting

Tracking Regulatory Feedback on Deviation Notifications Over Time

Posted on By digi

Tracking Regulatory Feedback on Deviation Notifications Over Time Tracking Regulatory Feedback on Deviation Notifications Over Time Understanding Deviation Notifications in Clinical Trials In clinical trials, it is imperative to adhere to protocols that ensure the integrity, safety, and efficacy of the research. A deviation can be defined as any departure from the trial protocol, which…

Read More “Tracking Regulatory Feedback on Deviation Notifications Over Time” »

Regulatory Notifications & IRB Reporting

Training Clinical, Regulatory and Medical Teams on Sponsor Transparency Governance

Posted on By digi

Training Clinical, Regulatory and Medical Teams on Sponsor Transparency Governance As the landscape of clinical research continues to evolve, the responsibility for ensuring transparency in sponsor governance has become increasingly critical. The integration of robust governance frameworks within clinical trials is essential for maintaining ethical standards and facilitating compliance with regulatory requirements. This comprehensive guide…

Read More “Training Clinical, Regulatory and Medical Teams on Sponsor Transparency Governance” »

Sponsor Transparency Governance

Using Sponsor Transparency Governance to Support Publications, HTA and Market Access

Posted on By digi

Using Sponsor Transparency Governance to Support Publications, HTA and Market Access Using Sponsor Transparency Governance to Support Publications, HTA and Market Access Introduction to Sponsor Transparency Governance In the evolving landscape of clinical research, particularly in the context of international regulatory requirements, sponsor transparency governance has gained increasing importance. This governance plays a crucial role…

Read More “Using Sponsor Transparency Governance to Support Publications, HTA and Market Access” »

Sponsor Transparency Governance

Templates, Checklists and Governance Models for Robust Pharmacy Manual, Lab Manual, Imaging Manual

Posted on By digi

Templates, Checklists and Governance Models for Robust Pharmacy Manual, Lab Manual, Imaging Manual Templates, Checklists and Governance Models for Robust Pharmacy Manual, Lab Manual, Imaging Manual In the realm of clinical trials, documentation plays a vital role in ensuring compliance, clarity, and operational efficiency. This article serves as a comprehensive step-by-step tutorial guide on creating…

Read More “Templates, Checklists and Governance Models for Robust Pharmacy Manual, Lab Manual, Imaging Manual” »

Pharmacy Manual, Lab Manual, Imaging Manual

Training Investigators on Their Regulatory Reporting Responsibilities

Posted on By digi

Training Investigators on Their Regulatory Reporting Responsibilities Training Investigators on Their Regulatory Reporting Responsibilities The management of regulatory reporting in clinical trials is a critical aspect that ensures compliance with various regulatory standards and the integrity of study findings. Understanding the responsibilities that investigators hold in this area is essential for clinical operations, regulatory affairs,…

Read More “Training Investigators on Their Regulatory Reporting Responsibilities” »

Regulatory Notifications & IRB Reporting

Remote and DCT-Specific Considerations for Deviation Notifications

Posted on By digi

Remote and DCT-Specific Considerations for Deviation Notifications Remote and DCT-Specific Considerations for Deviation Notifications As clinical trials increasingly transition to decentralized models, understanding the specific regulatory requirements surrounding protocol deviations becomes crucial. This article provides a comprehensive guide on handling deviation notifications in remote and decentralized clinical trials (DCTs). The guidelines will address the nuances…

Read More “Remote and DCT-Specific Considerations for Deviation Notifications” »

Regulatory Notifications & IRB Reporting

Integrating Sponsor Transparency Governance With Data Privacy, GDPR and HIPAA Requirements

Posted on By digi

Integrating Sponsor Transparency Governance With Data Privacy, GDPR and HIPAA Requirements In today’s clinical research environment, particularly in the context of sma clinical trials, the importance of sponsor transparency cannot be overstated. Ensuring that sponsor transparency governance aligns with data privacy requirements, particularly under the General Data Protection Regulation (GDPR) and the Health Insurance Portability…

Read More “Integrating Sponsor Transparency Governance With Data Privacy, GDPR and HIPAA Requirements” »

Sponsor Transparency Governance

Vendor and Partner Oversight Considerations for Sponsor Transparency Governance

Posted on By digi

Vendor and Partner Oversight Considerations for Sponsor Transparency Governance Vendor and Partner Oversight Considerations for Sponsor Transparency Governance In the evolving landscape of clinical research, the importance of sponsor transparency governance cannot be overstated, particularly for lecanemab trials. As clinical trials become increasingly complex, maintaining transparency and integrity in vendor and partner oversight is vital…

Read More “Vendor and Partner Oversight Considerations for Sponsor Transparency Governance” »

Sponsor Transparency Governance